Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression.
Tiziana CarandiniAnna Margherita PietroboniLuca SacchiMilena Alessandra De RizMattia PozzatoAndrea ArighiGiorgio Giulio FumagalliFilippo Martinelli-BoneschiDaniela GalimbertiElio ScarpiniPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2020)